Arcane supports innovation coming from its member laboratories, and which have potential for valorization. The transfer to industry is done in connection with the SATT Linksium, Floralis and CEA DRT entities which bring a critical analysis and reinforce the process of maturation of projects.
 

Recent projects funded by Arcane 

  • The project concerns an innovative approach to targeted photodynamic therapy with dual therapeutic action that can operate even in hypoxic environments
  • We aim to validate our axon growth promoting FUSED-1 peptide in vivo to repair the injured central nervous system
  • The CHEMRES project aims to develop an active, selective and non-toxic inhibitor of a protein involved in multidrug resistance during chemotherapy. Its therapeutic potential should be achieved when it is used in combinat...


View more